Results 161 to 170 of about 2,330 (177)

Efficacy and safety profile of elexacaftor-tezacaftor-ivacaftor triple therapy on cystic fibrosis: a systematic review and single arm meta-analysis

Frontiers in Pharmacology, 2023
Zijing Zhou, Zhihong Zuo, Zuo Zhihong
exaly  

Longitudinal Effects of Elexacaftor/Tezacaftor/Ivacaftor

CHEST
Sonia Graziano, Francesca Boldrini, Gaia Romana Pellicano, Francesco Milo, Fabio Majo, Luca Cristiani, Enza Montemitro, Federico Alghisi, Sergio Bella, Renato Cutrera, Alessandro Giovanni Fiocchi, Alexandra Quittner, Paola Tabarini   +12 more
openaire   +1 more source

Onset of systemic arterial hypertension after initiation of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis: A case series

Journal of Cystic Fibrosis, 2022
Andrea Gramegna, Gloria Leonardi, Martina Contarini   +2 more
exaly  

Elexacaftor–tezacaftor–ivacaftor as an essential medicine: an opportunity for action

The Lancet Respiratory Medicine
Jonathan, Guo, Andrew, Hill, Cassandra, Fairhead, Benedict, Young, Grace, Hennessy, Gayle, Pledger   +5 more
openaire   +2 more sources

Elexacaftor/tezacaftor/ivacaftor

Reactions Weekly
openaire   +1 more source

P344 Weight and wellbeing on elexacaftor/tezacaftor/ivacaftor

Journal of Cystic Fibrosis
L. Harneshaug, K. Westcott, A. Gurney, C. Van-Zwaneberg, C. Echevarria, S.J. Bourke   +5 more
openaire   +1 more source

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Lancet, The, 2019
Harry Heijerman, Edward F Mckone, Damian G Downey   +2 more
exaly  

Patent Review of Synthetic Routes and Crystalline Forms of the CFTR-Modulator Drugs Ivacaftor, Lumacaftor, Tezacaftor, and Elexacaftor

Organic Process Research and Development, 2019
David L Hughes
exaly  

Elexacaftor/tezacaftor/ivacaftor (Trikafta) for cystic fibrosis.

The Medical letter on drugs and therapeutics, 2020
openaire   +1 more source

Elexacaftor/tezacaftor/ivacaftor no tratamento da fibrose cística

2023
João Mateus de Oliveira Rodrigues, Cleber Jose da Silva   +1 more
openaire   +1 more source